UCL Technology Fund
Venture capitalLondon · Pre-Seed–Growth · 13 people tracked
Investment thesis
UCL Technology Fund backs founders and research teams commercialising physical and life sciences ideas originating from University College London. Investing since 2016, the fund supports the full commercialisation journey, from proof-of-concept and development projects through to company formation. It combines capital with scale-up expertise, helping researchers turn scientific discoveries into viable companies. The fund also engages in licensing projects and proof-of-concept investments as part of translating UCL research into commercial outcomes.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website
What they invest in
from 6 of 27 portfolio companiesAI & Machine Learning ×3Biotech ×2Deep Tech ×2Cleantech ×1Climate Tech ×1Developer Tools ×1Energy ×1Enterprise Software ×1
HQs:United Kingdom×1United States×1
Investments · 27 tracked
founders shown can be your intro pathClinical-stage gene therapy company developing treatments for ocular diseases (NASDAQ: MGTX).
Gigaton develops an AI control system that optimizes production processes in energy-intensive industries such as cement, glass, steel, and mining to reduce carbon emissions.
AI & Machine LearningCleantechClimate Tech
Biotech
James A. Geraghty(Director)Joanne T. Beck(Director)Marc Dunoyer(Director)Steven M. Altschuler(Director)Frank E. Thomas(Executive Officer)Alicia Secor(Director)
Humanloop was a development platform for building and managing large language model applications, providing tools for evaluating and managing AI systems.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Raza Habib(Founder)inJordan Burgess(Founder)inPeter Hayes(Founder)in
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)in
Clinical-stage biotechnology company (formerly Freeline Therapeutics) developing gene therapies for debilitating chronic conditions.
Exits · 1
IPOs and acquisitions across the tracked portfolioMeiraGTxNASDAQ: MGTX
Portfolio news
latest coverage across their companiesGaussion · startuprise.co.uk · Jun 29, 2026
Humanloop · news.crunchbase.com · Apr 2, 2026
Frequently asked questions
- What stage does UCL Technology Fund invest at?
- UCL Technology Fund invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What is UCL Technology Fund's typical check size?
- UCL Technology Fund typically writes checks of $320K – $9M.
- What sectors does UCL Technology Fund focus on?
- UCL Technology Fund focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, IoT, Longevity, New Materials.
- Where is UCL Technology Fund located?
- UCL Technology Fund is headquartered in London, GB.
Media · Podcasts & interviews
from their channelFounder Stories University Edition with Professor Tony Kenyon, CSO & Co-founder Intrinsic.
UCL Technology Fund
Founder Stories University Edition with Ashley Montanaro, CEO & Co-founder Phasecraft
UCL Technology Fund
Founder Stories University Edition with Professor Amit Nathwani, CEO NovalGen
UCL Technology Fund
Founder Stories: Rosalyn Moran, CEO Stanhope AI
UCL Technology Fund
UCLTF Showcase 2022 - Highlights
UCL Technology Fund
Universities supporting Climate Tech - UCLTF Climate Tech Webinar
UCL Technology Fund
Similar investors
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Ahren is an investment institution backing transformational companies at the intersection of deep tech and deep science, partnering with founders from pre-seed through pre-IPO across four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy.
Fundamental Ventures is an early-stage venture firm that backs founders removing fundamental constraints holding back human progress, spanning hard tech, deep science, and network/workflow innovations.
Northern Gritstone is a UK investment firm backing science and technology startups in the North of England, focused on university spinouts and early-stage companies across the Northern Arc region.